Pfizer: Kidney Failure, Chronic trials
The registry lists 10 Kidney Failure, Chronic studies with Pfizer as lead sponsor. 0 are open to participants now and 6 have results posted.
Phase 1 4Phase 3 5Phase 4 1(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Use Of Fragmin In HemodialysisCompletedNCT01879618Phase 3Results posted
- Pharmacokinetics And Dialysability Of CP-690,550 In Subjects With End-Stage Renal DiseaseCompletedNCT01710020Phase 1Results posted
- A Phase 3, Long-Term Safety Study of Subcutaneous Epoetin Hospira in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME -Anemia Management With EpoetinCompletedNCT01628120Phase 3Results posted
- A Phase 3, Long-Term Safety Study of Intravenous Epoetin Hospira in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME - Anemia Management With EpoetinCompletedNCT01628107Phase 3Results posted
- A Phase 3 Study Comparing the Effects of Subcutaneous Epoetin Hospira and Epoetin Alfa [Epogen] (Amgen) in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME - Anemia Management With EpoetinCompletedNCT01473420Phase 3Results posted
- A Phase 3 Study Comparing the Effects of Intravenous Epoetin Hospira and Epoetin Alfa [Epogen] (Amgen) in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME - Anemia Management With EpoetinCompletedNCT01473407Phase 3Results posted
- Study of GBT021601 in Participants With Renal ImpairmentTerminatedNCT05878704Phase 1
- Bosutinib In Subjects With Renal ImpairmentCompletedNCT01233882Phase 1
- A Study Comparing the Effects of Epoetin Hospira and Epogen/Epoetin Alfa (Amgen) When Administered IV in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance TreatmentCompletedNCT01170078Phase 1
- Study Evaluating Sirolimus in End Stage Renal Disease in High Risk Kidney Transplant RecipientsCompletedNCT00044720Phase 4